|
KMID : 1143720230190030298
|
|
Korean Journal of Neurotrauma
2023 Volume.19 No. 3 p.298 ~ p.306
|
|
|
Anticoagulation and Antiplatelet Agent Resumption Timing following Traumatic Brain Injury
|
|
Jung In-Ho
Yun Jung-Ho
Kim Sung-Jin
Chung Jae-Woo
Lee Sang-Koo
|
|
|
Abstract
|
|
|
|
Traumatic brain injury (TBI) is a major global health concern. Due to the increase in TBI incidence and the aging population, an increasing number of patients with TBI are taking antithrombotic agents for their underlying disease. When TBI occurs in patients with these diseases, there is a conflict between the disease, which requires an antithrombotic effect, and the neurosurgeon, who must minimize intracranial hemorrhage. Nevertheless, there are no clear guidelines for the reversal or resumption of antithrombotic agents when TBI occurs in patients taking antithrombotic agents. In this review article, we intend to classify antithrombotic agents and provide information on them. We also share previous studies on the reversal and resumption of antithrombotic agents in patients with TBI to help neurosurgeons in this dilemma.
|
|
|
KEYWORD
|
|
|
Traumatic brain injury, Antithrombotic agents, Anticoagulants, Antiplatelet agents
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|